TILS.L Regulatory News (TILS)

4 Nov 2008 13:10



4th November 2008

REGEN THERAPEUTICS PLC 

("ReGen" or the "Company"; Ticker: (RGT))

TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES

1.Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

2.Reason for the notification:

An acquisition or disposal of voting rights

3.Full name of person(s) subject to the notification obligation (iii):

Andrew Clement Wilson

4.Full name of shareholder(s) (if difference from 3):

As Above

5.Date of the transaction and date on which the threshold is crossed or reached (v):

3rd November 2008

6.Date on which issued notified:

4th November 2008

7.Threshold(s) that is/are crossed or reached:

13%

8.Notified details 

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code GB00B28XMY25

Situation Previous to the triggering transaction (vi) -

Number of Shares 1,720,000

Number of Voting Rights (viii) 1,720,000

Resulting situation after the triggering transaction (viii) -

Number of Shares 1,870,750

Number of Voting Rights - Direct (x) 1,870,750

Number of Voting Rights - Indirect (xi) N/A

% of voting rights - Direct 13.45

% of voting rights - Indirect N/A

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument N/A

Expiration date (xiii) N/A

Exercise/Conversion Period/Date (xiv) N/A

Number of voting rights that may be acquired if the 

instrument is exercised/converted N/A

% of voting rights N/A

Total (A+B)

Number of voting rights 1,870,750

% of voting rights 13.45

9.Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Giltspur Nominees Limited-Brewin Dolphin

Proxy Voting:

10.Name of the proxy holder: N/A

11.Number of voting rights proxy holder will cease to hold: N/A

12.Date on which proxy holder will cease to hold voting rights:  N/A

13.Additional information: Brewin Dolphin act as

  Broker to client

14.Contact name: Patrick Wilson

15.Contact telephone number: 028 90 446000

For further information:

For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396